Live Breaking News & Updates on Madhuri Vusirikala

Stay updated with breaking news from Madhuri vusirikala. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Actinium Announces Positive Full Data Results From the Pivotal Phase 3 SIERRA Trial in Patients with Active, Relapsed or Refractory Acute Myeloid Leukemia

Actinium Announces Positive Full Data Results From the Pivotal Phase 3 SIERRA Trial in Patients with Active, Relapsed or Refractory Acute Myeloid Leukemia
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Madhuri Vusirikala , Caroline Yarbrough , Sandesh Seth , Venetoclax Bcl , Sergio Giralt , Avinash Desai , Division Of Hematologic Malignancies , Service At Memorial Sloan Kettering Cancer Center , Actinium Pharmaceuticals Inc , European Medicines Agency , Hans Vitzthumlifesci Advisors , Committee For Medicinal Products Human Use , Clinical Development , Fred Hutchinson Cancer Research Center , Prnewswire Actinium Pharmaceuticals Inc , Complete Remission , Event Free Survival , Hazard Ratio , Conference Call , Webcast Details , Chief Medical , Chief Commercial , Deputy Head , Hematologic Malignancies , Attending Physician ,

Actinium Announces Positive Full Data Results From the Pivotal Phase 3 SIERRA Trial in Patients with Active, Relapsed or Refractory Acute Myeloid Leukemia

- Iomab-B met the primary endpoint of durable Complete Remission (dCR) of 6-months following initial complete remission after BMT with high statistical. ....

United States , Madhuri Vusirikala , Caroline Yarbrough , Sandesh Seth , Hans Vitzthum , Venetoclax Bcl , Sergio Giralt , Avinash Desai , Lifesci Advisors , Actinium Pharmaceuticals Inc , Division Of Hematologic Malignancies , Service At Memorial Sloan Kettering Cancer Center , Clinical Development , Complete Remission , Actinium Pharmaceuticals , Investor Conference Call , Webcast Details , Chief Medical , Chief Commercial , Deputy Head , Hematologic Malignancies , Attending Physician , Memorial Sloan Kettering Cancer Center , After Initial , Secondary Endpoints , Event Free Survival ,

Actinium Expands Clinical Leadership Team to Support Key Development Programs for Iomab-B and Actimab-A

/PRNewswire/ Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a leader in the development of targeted radiotherapies, today. ....

New York , United States , Memorial Sloan Kettering Cancer Center , Drexel University , Yeshiva University , Madhya Pradesh , Montefiore Einstein , Akash Nahar , Madhuri Vusirikala , Elaina Haeuber , Hans Vitzthum , Patrik Brodin , Avinash Desai , Vanderbilt University Medical Center , Physics At Lund University , University Of New York , Head Of Radiation Sciences , American Society Of Transplantation , Boston University , Syneos Health , Actinium Pharmaceuticals Inc , Enrollment Solutions , India Lady Hardinge Medical College , University Of Copenhagen , Adult Allogeneic Bone Marrow Transplant Program , Niels Bohr Institute ,